{
  "success": true,
  "sourceFile": "input/Alexion_NCT04573309_Wilsons_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33
  ],
  "modelUsed": "gemini-2.5-pro",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Screened Set",
        "text": "The Screened Set includes all participants who signed an informed consent form (ICF).",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "populationDescription": "The Screened Set includes all participants who signed an informed consent form (ICF).",
        "criteria": "Signed ICF"
      },
      {
        "id": "pop_2",
        "name": "Enrolled Set",
        "text": "The Enrolled Set includes all participants who signed an ICF and were enrolled in the study.",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "populationDescription": "The Enrolled Set includes all participants who signed an ICF and were enrolled in the study.",
        "criteria": "Signed ICF AND enrolled in the study"
      },
      {
        "id": "pop_3",
        "name": "Full Analysis Set",
        "text": "The Full Analysis (FA) Set includes all participants who were enrolled and received at least 1 dose of study drug. The FA Set will be used for all efficacy analyses.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FA",
        "populationDescription": "The Full Analysis (FA) Set includes all participants who were enrolled and received at least 1 dose of study drug. The FA Set will be used for all efficacy analyses.",
        "criteria": "Enrolled AND received >=1 dose of study drug"
      },
      {
        "id": "pop_4",
        "name": "Per Protocol Set",
        "text": "The Per Protocol (PP) Set includes all participants in the FA Set who do not have any major protocol deviations that would impact the interpretability of the efficacy data. The PP Set will be used for sensitivity analyses of the primary efficacy endpoint. Major protocol deviations will be identified and documented before database lock.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP",
        "populationDescription": "The Per Protocol (PP) Set includes all participants in the FA Set who do not have any major protocol deviations that would impact the interpretability of the efficacy data. The PP Set will be used for sensitivity analyses of the primary efficacy endpoint. Major protocol deviations will be identified and documented before database lock.",
        "criteria": "Member of FA Set AND no major protocol deviations impacting efficacy"
      },
      {
        "id": "pop_5",
        "name": "Safety Set",
        "text": "The Safety Set includes all participants who received at least 1 dose of study drug. The Safety Set will be used for all safety analyses.",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "populationDescription": "The Safety Set includes all participants who received at least 1 dose of study drug. The Safety Set will be used for all safety analyses.",
        "criteria": "Received >=1 dose of study drug"
      },
      {
        "id": "pop_6",
        "name": "Pharmacokinetic Analysis Set",
        "text": "The Pharmacokinetic (PK) Analysis Set includes all participants in the Safety Set who have sufficient plasma concentration data to allow for the derivation of at least 1 PK parameter. The PK Analysis Set will be used for all PK analyses.",
        "populationType": "PK/PD",
        "instanceType": "AnalysisPopulation",
        "label": "PK",
        "populationDescription": "The Pharmacokinetic (PK) Analysis Set includes all participants in the Safety Set who have sufficient plasma concentration data to allow for the derivation of at least 1 PK parameter. The PK Analysis Set will be used for all PK analyses.",
        "criteria": "Member of Safety Set AND has sufficient data for >=1 PK parameter"
      },
      {
        "id": "pop_7",
        "name": "Pharmacodynamic Analysis Set",
        "text": "The Pharmacodynamic (PD) Analysis Set includes all participants in the Safety Set who have sufficient PD data to allow for the derivation of at least 1 PD parameter. The PD Analysis Set will be used for all PD analyses.",
        "populationType": "PK/PD",
        "instanceType": "AnalysisPopulation",
        "label": "PD",
        "populationDescription": "The Pharmacodynamic (PD) Analysis Set includes all participants in the Safety Set who have sufficient PD data to allow for the derivation of at least 1 PD parameter. The PD Analysis Set will be used for all PD analyses.",
        "criteria": "Member of Safety Set AND has sufficient data for >=1 PD parameter"
      }
    ],
    "characteristics": [],
    "summary": {
      "populationCount": 7,
      "characteristicCount": 0
    }
  }
}